Showing 1 - 6 results of 6 for search 'Torsten Schaller', query time: 0.01s Refine Results
  1. 1
    Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.

    Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. by Ravindra K Gupta, Stéphane Hué, Torsten Schaller, Ernst Verschoor, Deenan Pillay, Greg J Towers

    Published 2009-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.

    Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1. by Luis Apolonia, Reiner Schulz, Tomaž Curk, Paula Rocha, Chad M Swanson, Torsten Schaller, Jernej Ule, Michael H Malim

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    CPSF6 defines a conserved capsid interface that modulates HIV-1 replication.

    CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. by Amanda J Price, Adam J Fletcher, Torsten Schaller, Tom Elliott, KyeongEun Lee, Vineet N KewalRamani, Jason W Chin, Greg J Towers, Leo C James

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2.

    HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. by Karen E Ocwieja, Troy L Brady, Keshet Ronen, Alyssa Huegel, Shoshannah L Roth, Torsten Schaller, Leo C James, Greg J Towers, John A T Young, Sumit K Chanda, Renate König, Nirav Malani, Charles C Berry, Frederic D Bushman

    Published 2011-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.

    HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. by Torsten Schaller, Karen E Ocwieja, Jane Rasaiyaah, Amanda J Price, Troy L Brady, Shoshannah L Roth, Stéphane Hué, Adam J Fletcher, KyeongEun Lee, Vineet N KewalRamani, Mahdad Noursadeghi, Richard G Jenner, Leo C James, Frederic D Bushman, Greg J Towers

    Published 2011-12-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy

    Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy by Sean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, Cynthia BJ Paulin, Lakshmi Sandhow, Juliane Kutzner, Ida Hed Myrberg, Sarah S Bunten, Hanna Axelsson, Si Min Zhang, Azita Rasti, Petri Mäkelä, Si'Ana A Coggins, Sijia Tao, Sharda Suman, Rui M Branca, Georgios Mermelekas, Elisée Wiita, Sun Lee, Julian Walfridsson, Raymond F Schinazi, Baek Kim, Janne Lehtiö, Georgios Z Rassidakis, Katja Pokrovskaja Tamm, Ulrika Warpman‐Berglund, Mats Heyman, Dan Grandér, Sören Lehmann, Thomas Lundbäck, Hong Qian, Jan‐Inge Henter, Torsten Schaller, Thomas Helleday, Nikolas Herold

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: